1. Home
  2. NKTX vs ILPT Comparison

NKTX vs ILPT Comparison

Compare NKTX & ILPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • ILPT
  • Stock Information
  • Founded
  • NKTX 2015
  • ILPT 2017
  • Country
  • NKTX United States
  • ILPT United States
  • Employees
  • NKTX N/A
  • ILPT N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • ILPT Real Estate Investment Trusts
  • Sector
  • NKTX Health Care
  • ILPT Real Estate
  • Exchange
  • NKTX Nasdaq
  • ILPT Nasdaq
  • Market Cap
  • NKTX 225.1M
  • ILPT 235.1M
  • IPO Year
  • NKTX 2020
  • ILPT 2018
  • Fundamental
  • Price
  • NKTX $2.45
  • ILPT $3.70
  • Analyst Decision
  • NKTX Strong Buy
  • ILPT Buy
  • Analyst Count
  • NKTX 5
  • ILPT 2
  • Target Price
  • NKTX $17.00
  • ILPT $10.00
  • AVG Volume (30 Days)
  • NKTX 1.2M
  • ILPT 449.6K
  • Earning Date
  • NKTX 11-07-2024
  • ILPT 10-29-2024
  • Dividend Yield
  • NKTX N/A
  • ILPT 1.08%
  • EPS Growth
  • NKTX N/A
  • ILPT N/A
  • EPS
  • NKTX N/A
  • ILPT N/A
  • Revenue
  • NKTX N/A
  • ILPT $440,696,000.00
  • Revenue This Year
  • NKTX N/A
  • ILPT N/A
  • Revenue Next Year
  • NKTX N/A
  • ILPT $6.87
  • P/E Ratio
  • NKTX N/A
  • ILPT N/A
  • Revenue Growth
  • NKTX N/A
  • ILPT 1.36
  • 52 Week Low
  • NKTX $2.38
  • ILPT $2.93
  • 52 Week High
  • NKTX $16.24
  • ILPT $5.45
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 26.80
  • ILPT 42.40
  • Support Level
  • NKTX $2.40
  • ILPT $3.57
  • Resistance Level
  • NKTX $3.81
  • ILPT $3.84
  • Average True Range (ATR)
  • NKTX 0.25
  • ILPT 0.15
  • MACD
  • NKTX -0.02
  • ILPT 0.04
  • Stochastic Oscillator
  • NKTX 4.90
  • ILPT 43.90

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

About ILPT Industrial Logistics Properties Trust of Beneficial Interest

Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.

Share on Social Networks: